Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Schizophrenia

  Free Subscription


12.03.2018

2 Acta Psychiatr Scand
3 Am J Psychiatry
1 Biol Psychiatry
1 Br J Psychiatry
1 Cereb Cortex
1 Compr Psychiatry
1 J Clin Psychopharmacol
3 Mol Psychiatry
2 Neuropsychopharmacology
2 Pharmacopsychiatry
6 Psychiatry Res
3 Psychol Med
22 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. SUETANI S, Siskind D, Scott JG, McGrath JJ, et al
    Disentangling schizophrenia spectrum disorders.
    Acta Psychiatr Scand. 2018;137:365-366.
    PubMed     Text format    

  2. CULLEN B, Smith DJ, Deary IJ, Evans JJ, et al
    The 'cognitive footprint' of psychiatric and neurological conditions: cross-sectional study in the UK Biobank cohort.
    Acta Psychiatr Scand. 2017;135:593-605.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  3. ANDERSON KK, Norman R, MacDougall A, Edwards J, et al
    Effectiveness of Early Psychosis Intervention: Comparison of Service Users and Nonusers in Population-Based Health Administrative Data.
    Am J Psychiatry. 2018 Mar 2:appiajp201717050480.
    PubMed     Text format     Abstract available

  4. KAUPPI K, Rosenthal SB, Lo MT, Sanyal N, et al
    Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.
    Am J Psychiatry. 2018 Mar 2:appiajp201717040410.
    PubMed     Text format     Abstract available

  5. NOORDSY DL, Burgess JD, Hardy KV, Yudofsky LM, et al
    Therapeutic Potential of Physical Exercise in Early Psychosis.
    Am J Psychiatry. 2018;175:209-214.
    PubMed     Text format    


    Biol Psychiatry

  6. D'SOUZA DC, Carson RE, Driesen N, Johannesen J, et al
    Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects.
    Biol Psychiatry. 2018 Jan 31. pii: S0006-3223(18)30036.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  7. TURKINGTON D, Spencer H, Lebert L, Dudley R, et al
    Befriending: active placebo or effective psychotherapy?
    Br J Psychiatry. 2017;211:5-6.
    PubMed     Text format     Abstract available


    Cereb Cortex

  8. RENARD J, Rosen LG, Loureiro M, De Oliveira C, et al
    Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex.
    Cereb Cortex. 2017;27:1297-1310.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  9. ONWUMERE J, Sirykaite S, Schulz J, Man E, et al
    Understanding the experience of "burnout" in first-episode psychosis carers.
    Compr Psychiatry. 2018;83:19-24.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  10. JONES C
    alpha7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    J Clin Psychopharmacol. 2018 Mar 2. doi: 10.1097/JCP.0000000000000859.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  11. KENDLER KS
    The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900.
    Mol Psychiatry. 2017;22:1539-1553.
    PubMed     Text format     Abstract available

  12. SULLIVAN CR, Koene RH, Hasselfeld K, O'Donovan SM, et al
    Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.
    Mol Psychiatry. 2018 Mar 1. pii: 10.1038/s41380-018-0035.
    PubMed     Text format     Abstract available

  13. OSIMO EF, Beck K, Reis Marques T, Howes OD, et al
    Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Mol Psychiatry. 2018 Mar 6. pii: 10.1038/s41380-018-0041.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  14. CHIAPPELLI J, Notarangelo FM, Pocivavsek A, Thomas MAR, et al
    Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia.
    Neuropsychopharmacology. 2018 Feb 27. pii: 10.1038/s41386-018-0038.
    PubMed     Text format     Abstract available

  15. BARNETT I, Torous J, Staples P, Sandoval L, et al
    Relapse prediction in schizophrenia through digital phenotyping: a pilot study.
    Neuropsychopharmacology. 2018 Feb 22. pii: 10.1038/s41386-018-0030.
    PubMed     Text format     Abstract available


    Pharmacopsychiatry

  16. KISHI T, Matsui Y, Matsuda Y, Katsuki A, et al
    Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pharmacopsychiatry. 2018 Mar 7. doi: 10.1055/a-0574-0088.
    PubMed     Text format     Abstract available

  17. ROSER P, Pichler EM, Habermeyer B, Kawohl W, et al
    Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients.
    Pharmacopsychiatry. 2018 Mar 5. doi: 10.1055/a-0573-9866.
    PubMed     Text format     Abstract available


    Psychiatry Res

  18. WOOD L, Byrne R, Enache G, Morrison AP, et al
    A brief cognitive therapy intervention for internalised stigma in acute inpatients who experience psychosis: A feasibility randomised controlled trial.
    Psychiatry Res. 2017;262:303-310.
    PubMed     Text format     Abstract available

  19. SUM MY, Tay KH, Sengupta S, Sim K, et al
    Neurocognitive functioning and quality of life in patients with and without deficit syndrome of schizophrenia.
    Psychiatry Res. 2018;263:54-60.
    PubMed     Text format     Abstract available

  20. BRIEND F, Nathou C, Kauffmann F, Delcroix N, et al
    Theta burst stimulation on social cognition and N-Acetyl aspartate in two patients with schizophrenia.
    Psychiatry Res. 2018 Feb 18. pii: S0925-4927(17)30344.
    PubMed     Text format    

  21. LI X, Tian Q, Bo Q, Zhang G, et al
    Impact of childhood trauma on sensorimotor gating in Chinese patients with chronic schizophrenia.
    Psychiatry Res. 2018;263:69-73.
    PubMed     Text format     Abstract available

  22. PAUSELLI L, Halpern B, Cleary SD, Ku B, et al
    Computational linguistic analysis applied to a semantic fluency task to measure derailment and tangentiality in schizophrenia.
    Psychiatry Res. 2018;263:74-79.
    PubMed     Text format     Abstract available

  23. AIKAWA S, Kobayashi H, Nemoto T, Matsuo S, et al
    Social anxiety and risk factors in patients with schizophrenia: Relationship with duration of untreated psychosis.
    Psychiatry Res. 2018;263:94-100.
    PubMed     Text format     Abstract available


    Psychol Med

  24. ESCOTT-PRICE V, Smith DJ, Kendall K, Ward J, et al
    Polygenic risk for schizophrenia and season of birth within the UK Biobank cohort.
    Psychol Med. 2018 Mar 4:1-6. doi: 10.1017/S0033291718000454.
    PubMed     Text format     Abstract available

  25. BECK AT, Himelstein R, Bredemeier K, Silverstein SM, et al
    What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors.
    Psychol Med. 2018 Mar 4:1-10. doi: 10.1017/S0033291718000442.
    PubMed     Text format     Abstract available

  26. STABLEIN M, Storchak H, Ghinea D, Kraft D, et al
    Visual working memory encoding in schizophrenia and first-degree relatives: neurofunctional abnormalities and impaired consolidation.
    Psychol Med. 2018 Mar 9:1-9. doi: 10.1017/S003329171800051.
    PubMed     Text format     Abstract available


    Schizophr Res

  27. FERNANDEZ VG, Asarnow R, Narr KL, Subotnik KL, et al
    Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30114.
    PubMed     Text format     Abstract available

  28. GOLDSMITH DR, Haroon E, Miller AH, Strauss GP, et al
    TNF-alpha and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30129.
    PubMed     Text format     Abstract available

  29. STRAUSS GP, Visser KF, Keller WR, Gold JM, et al
    Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30090.
    PubMed     Text format     Abstract available

  30. BALZAN RP, Dhillon VS, Liu D, Hahn L, et al
    Shorter telomere length in people with schizophrenia who live alone?
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30115.
    PubMed     Text format    

  31. MOHNKE M, Bach C, Roesch-Ely D
    Proverb comprehension deficits in patients with schizophrenia-Neurocognitive and social cognitive correlates.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30124.
    PubMed     Text format    

  32. KIM P, Scott MR, Meador-Woodruff JH
    Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2018 Feb 26. pii: S0920-9964(18)30059.
    PubMed     Text format     Abstract available

  33. RAMSAUER B, Achtergarde S
    Mothers with acute and chronic postpartum psychoses and impact on the mother-infant interaction.
    Schizophr Res. 2018 Feb 26. pii: S0920-9964(18)30109.
    PubMed     Text format     Abstract available

  34. JAKOBSEN MI, Fink-Jensen A
    Eosinopenia in women with schizophrenia: Drug-induced or a sign of gender specific difference in pathogenesis?
    Schizophr Res. 2018 Feb 25. pii: S0920-9964(18)30056.
    PubMed     Text format    

  35. CZAJA SJ, Loewenstein DA, Lee CC, Fu SH, et al
    Assessing functional performance using computer-based simulations of everyday activities.
    Schizophr Res. 2017;183:130-136.
    PubMed     Text format     Abstract available

  36. HOU Y, Liang W, Zhang J, Li Q, et al
    Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30116.
    PubMed     Text format     Abstract available

  37. STORCH JAKOBSEN A, Speyer H, Norgaard HCB, Hjorthoj C, et al
    Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Schizophr Res. 2018 Feb 28. pii: S0920-9964(18)30127.
    PubMed     Text format     Abstract available

  38. VOGEL BO, Stasch J, Walter H, Neuhaus AH, et al
    Emotional context restores cortical prediction error responses in schizophrenia.
    Schizophr Res. 2018 Feb 28. pii: S0920-9964(18)30107.
    PubMed     Text format     Abstract available

  39. SCHEFFLER F, Kilian S, Chiliza B, Asmal L, et al
    Effects of cannabis use on body mass, fasting glucose and lipids during the first 12months of treatment in schizophrenia spectrum disorders.
    Schizophr Res. 2018 Mar 6. pii: S0920-9964(18)30128.
    PubMed     Text format     Abstract available

  40. MORIYAMA Y, Kotani T, Ushida T, Imai K, et al
    Altered proteomic profile in umbilical arterial serum from mothers with schizophrenia.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30101.
    PubMed     Text format    

  41. CAVELTI M, Kircher T, Nagels A, Strik W, et al
    Is formal thought disorder in schizophrenia related to structural and functional aberrations in the language network? A systematic review of neuroimaging findings.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30131.
    PubMed     Text format     Abstract available

  42. CHENG WJ, Chen CH, Chen CK, Huang MC, et al
    Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30130.
    PubMed     Text format     Abstract available

  43. SHAN L, Liu T, Zhang Z, Liu Q, et al
    Schizophrenia-like olfactory dysfunction induced by acute and postnatal phencyclidine exposure in rats.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30125.
    PubMed     Text format     Abstract available

  44. RUND BR
    The association between schizophrenia and violence.
    Schizophr Res. 2018 Mar 2. pii: S0920-9964(18)30123.
    PubMed     Text format    

  45. MENG XD, Cao X, Li T, Li JP, et al
    Creatine kinase (CK) and its association with aggressive behavior in patients with schizophrenia.
    Schizophr Res. 2018 Mar 2. pii: S0920-9964(18)30104.
    PubMed     Text format     Abstract available

  46. PAIPA N, Stephan-Otto C, Cuevas-Esteban J, Nunez-Navarro A, et al
    Second-to-fourth digit length ratio is associated with negative and affective symptoms in schizophrenia patients.
    Schizophr Res. 2018 Mar 1. pii: S0920-9964(18)30113.
    PubMed     Text format     Abstract available

  47. BILLINGSLEY KJ, Manca M, Gianfrancesco O, Collier DA, et al
    Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.
    Schizophr Res. 2018 Feb 28. pii: S0920-9964(18)30111.
    PubMed     Text format     Abstract available

  48. OSBORN D, Marston L, Nazareth I, King MB, et al
    Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine.
    Schizophr Res. 2017;183:116-123.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: